Amgen Inc.
DECREASING ORNITHINE METABOLISM TO DECREASE THE HIGH MANNOSE GLYCOFORM CONTENT OF RECOMBINANT PROTEINS
Last updated:
Abstract:
The present invention relates to a method for manipulating the high mannose glycoform content of recombinant glycoproteins by regulating ornithine metabolism during cell culture.
Status:
Application
Type:
Utility
Filling date:
6 Nov 2019
Issue date:
5 Mar 2020